Trial Profile
A Placebo-controlled Single-blinded Study of Aramchol with Supplemental Vitamin D in Patients with Vitamin D Deficiency and Nonalcoholic Fatty Liver Disease (NAFLD) and Fibrosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 May 2016
Price :
$35
*
At a glance
- Drugs Icomidocholic acid (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 09 May 2016 New trial record